Skip to main content
Premium Trial:

Request an Annual Quote

Nycomed Rethinks Plans for Amersham Unit

Premium

Anglo-Norwegian healthcare group Nycomed is evaluating the structure of its Amersham Pharmacia Biotech unit, which is 45 percent owned by Pharmacia, Reuters reported.

 

According to the report, Nycomed CEO Bill Castell said that the company was considering increasing its stake in APB as well as floating the unit

 

An announcement on the new structure is expected soon.

 

Meanwhile, APB said it will create about 200 new jobs, which will nearly double its workforce to 475 employees.

 

Most of the job openings will be in research and development at the company’s recently unveiled genomics center at its Silicon Valley-based subsidiary, Molecular Dynamics in Sunnyvale, Calif.

 

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.